Universal Biosensors (ASX:UBI) signed a non-exclusive deal with Henry Schein, an American distributor of dental and medical supplies, according to a Friday filing with the Australian bourse.
The agreement covers the distribution of the company's coagulation monitoring device, Xprecia Prime, throughout the US, the filing said.
The deal is for a year with provisions for annual extensions by agreement, as per the filing.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。